Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Antimicrob Agents Chemother
2004 May 01;485:1526-33. doi: 10.1128/AAC.48.5.1526-1533.2004.
Show Gene links
Show Anatomy links
Antibacterial activities of rhodamine B-conjugated gelsolin-derived peptides compared to those of the antimicrobial peptides cathelicidin LL37, magainin II, and melittin.
Bucki R
,
Pastore JJ
,
Randhawa P
,
Vegners R
,
Weiner DJ
,
Janmey PA
.
???displayArticle.abstract???
The growing number of antibiotic-resistant bacteria necessitates the search for new antimicrobial agents and the principles by which they work. We report that cell membrane-permeant rhodamine B (RhB)-conjugated peptides based on the phosphatidylinositol-4,5-bisphosphate binding site of gelsolin can kill the gram-negative organisms Escherichia coli and Pseudomonas aeruginosa and the gram-positive organism Streptococcus pneumoniae. RhB linkage to the QRLFQVKGRR sequence in gelsolin was essential for the antibacterial function, since the unconjugated peptide had no effect on the bacteria tested. Because RhB-QRLFQVKGRR (also termed PBP10), its scrambled sequence (RhB-FRVKLKQGQR), and PBP10 synthesized from D-isomer amino acids show similar antibacterial properties, the physical and chemical properties of these derivatives appear to be more important than specific peptide folding for their antibacterial functions. The similar activities of PBP10 and all-D-amino-acid PBP10 also indicate that a specific interaction between RhB derivatives and bacterial proteins is unlikely to be involved in the bacterial killing function of PBP10. By using a phospholipid monolayer system, we found a positive correlation between the antibacterial function of PBP10, as well as some naturally occurring antibacterial peptides, and the intrinsic surface pressure activity at the hydrophobic-hydrophilic interface. Surprisingly, we observed little or no dependence of the insertion of these peptides into lipid monolayers on the phospholipid composition. These studies show that an effective antimicrobial agent can be produced from a peptide sequence with specificity to a phospholipid not found in bacteria, and comparisons with other antimicrobial agents suggest that the surface activities of these peptides are more important than specific binding to bacterial proteins or lipids for their antimicrobial functions.
Avrahami,
Conjugation of a magainin analogue with lipophilic acids controls hydrophobicity, solution assembly, and cell selectivity.
2002, Pubmed,
Xenbase
Avrahami,
Conjugation of a magainin analogue with lipophilic acids controls hydrophobicity, solution assembly, and cell selectivity.
2002,
Pubmed
,
Xenbase
Bland,
All-D-cecropin B: synthesis, conformation, lipopolysaccharide binding, and antibacterial activity.
2001,
Pubmed
Boman,
Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine.
1993,
Pubmed
Brockman,
Lipid monolayers: why use half a membrane to characterize protein-membrane interactions?
1999,
Pubmed
Bucki,
Involvement of phosphatidylinositol 4,5-bisphosphate in phosphatidylserine exposure in platelets: use of a permeant phosphoinositide-binding peptide.
2001,
Pubmed
Cunningham,
Cell permeant polyphosphoinositide-binding peptides that block cell motility and actin assembly.
2001,
Pubmed
Demel,
The specific interaction of myelin basic protein with lipids at the air-water interface.
1973,
Pubmed
De Yang,
LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells.
2000,
Pubmed
Foster,
The distribution of polyphosphoinositides in lipid films.
2001,
Pubmed
Friedrich,
Salt-resistant alpha-helical cationic antimicrobial peptides.
1999,
Pubmed
Gallo,
Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds.
1994,
Pubmed
Guttman,
Gelsolin--evidence for a role in turnover of junction-related actin filaments in Sertoli cells.
2002,
Pubmed
Johansson,
Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37.
1998,
Pubmed
Kourie,
Properties of cytotoxic peptide-formed ion channels.
2000,
Pubmed
,
Xenbase
Larrick,
Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein.
1995,
Pubmed
Larrick,
A novel granulocyte-derived peptide with lipopolysaccharide-neutralizing activity.
1994,
Pubmed
Lee,
Design of novel analogue peptides with potent antibiotic activity based on the antimicrobial peptide, HP (2-20), derived from N-terminus of Helicobacter pylori ribosomal protein L1.
2002,
Pubmed
Lee,
Design and synthesis of novel antimicrobial pseudopeptides with selective membrane-perturbation activity.
2000,
Pubmed
Lee,
Design of novel peptide analogs with potent fungicidal activity, based on PMAP-23 antimicrobial peptide isolated from porcine myeloid.
2002,
Pubmed
Medina,
Binding of novel peptide inhibitors of type IV collagenases to phospholipid membranes and use in liposome targeting to tumor cells in vitro.
2001,
Pubmed
Ogasawara,
Pulmonary surfactant protein D specifically binds to phosphatidylinositol.
1992,
Pubmed
Oh,
Role of the hinge region and the tryptophan residue in the synthetic antimicrobial peptides, cecropin A(1-8)-magainin 2(1-12) and its analogues, on their antibiotic activities and structures.
2000,
Pubmed
,
Xenbase
Rozgonyi,
Lipid extraction and phospholipid phosphorus determination in Gram-positive bacteria.
1980,
Pubmed
Sai,
Bile acid secretion and direct targeting of mdr1-green fluorescent protein from Golgi to the canalicular membrane in polarized WIF-B cells.
1999,
Pubmed
Shin,
CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity.
2000,
Pubmed
Silvestro,
Antibacterial and antimembrane activities of cecropin A in Escherichia coli.
2000,
Pubmed
Skerlavaj,
Rapid membrane permeabilization and inhibition of vital functions of gram-negative bacteria by bactenecins.
1990,
Pubmed
Taneva,
Adsorption of pulmonary surfactant protein D to phospholipid monolayers at the air-water interface.
1997,
Pubmed
Travis,
Bactericidal activity of mammalian cathelicidin-derived peptides.
2000,
Pubmed
Xian,
Spectroscopic studies of a phosphoinositide-binding peptide from gelsolin: behavior in solutions of mixed solvent and anionic micelles.
1995,
Pubmed
Yang,
The role of mammalian antimicrobial peptides and proteins in awakening of innate host defenses and adaptive immunity.
2001,
Pubmed
Zanetti,
Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain.
1995,
Pubmed
Zanetti,
Structure and biology of cathelicidins.
2000,
Pubmed
Zanetti,
The cathelicidin family of antimicrobial peptide precursors: a component of the oxygen-independent defense mechanisms of neutrophils.
1997,
Pubmed
Zendzian-Piotrowska,
Diabetes affects phospholipid content in the nuclei of the rat liver.
2000,
Pubmed
Zhao,
Comparison of the membrane association of two antimicrobial peptides, magainin 2 and indolicidin.
2001,
Pubmed
,
Xenbase
Zhao,
Modulation of the activity of secretory phospholipase A2 by antimicrobial peptides.
2003,
Pubmed
,
Xenbase
